Decline of RSV-specific antibodies during the COVID-19 pandemic.

den Hartog, Gerco; van Kasteren, Puck B; Schepp, Rutger M; Teirlinck, Anne C; van der Klis, Fiona R M; van Binnendijk, Robert S

den Hartog, Gerco; van Kasteren, Puck B; Schepp, Rutger M; Teirlinck, Anne C; van der Klis, Fiona R M; van Binnendijk, Robert S.

Affiliation

den Hartog G; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands. Electronic address: gerco.den.hartog@rivm.nl.
van Kasteren PB; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
Schepp RM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
Teirlinck AC; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
van der Klis FRM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.
van Binnendijk RS; Center for Infectious Disease Control, National Institute for Public Health and the Environment, 3721 Bilthoven, Netherlands.

Lancet Infect Dis ; 23(1): 23-25, 2023 01.

Article in En | MEDLINE | ID: mdl-36463892

Subject(s)

COVID-19; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Humans; Pandemics; Antibodies, Neutralizing; Respiratory Syncytial Virus Infections/epidemiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Syncytial Virus, Human / Respiratory Syncytial Virus Infections / COVID-19 Limits: Humans Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2023 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google